Joe Biden has just signed a historic cannabis research bill into law. The cannabis research bill passed the House of Representatives in July and the Senate last month. The U.S. Attorney General now has 60 days to either approve the application or request additional information before the cannabis research bill becomes law. The signing follows Biden’s recent pardoning of federal cannabis offenses.
Joe Biden Signs Cannabis Research Bill
U.S. President Joe Biden has officially signed a cannabis research bill into law. In doing so, he makes history by signing into law the first stand-alone federal cannabis reform legislation in the United States.
To follow the changes this bill will bring about as they unfold, download our free cannabis news app.
Cannabis Research Bill Passed Senate Last Month
The cannabis research bill passed the House of Representatives in July and the Senate last month. A White House spokesperson had confirmed to Marijuana Moment that the president intended to sign it. He did so on Friday.
The U.S. Attorney General now has 60 days to either approve the application or request additional information before the cannabis research bill becomes law.
Cannabis Research Bill Provisions
Among many provisions, the text creates a more efficient pathway for researchers to request larger quantities of cannabis.
The U.S. president remains opposed to federal legalization of cannabis, but he has campaigned on a number of smaller reforms around cannabis, including promoting research, decriminalization, and reclassifying cannabis as a controlled substance (CSA). The signing of the cannabis research bill is a step in the right direction on one of those objectives.
Cannabis Research Bill Follows Mass Pardoning
In October, prior to signing the cannabis research bill, Joe Biden also issued a mass pardon to Americans with federal cannabis possession offenses and ordered an administrative review of cannabis classification. The White House recently ranked these actions among the president’s “top accomplishments.”
Joint Statement Applauds Biden
The four co-chairs of the Congressional Cannabis Caucus – Democrats Earl Blumenauer and Barbara Lee and Republicans Dave Joyce and Brian Mast – issued a joint statement after the president’s signature:
“For decades, the federal government has stood in the way of science and progress with its misguided and discriminatory approach to cannabis. Today marks a monumental step in turning our federal cannabis laws around,” they said. “The Medical Cannabis and Cannabidiol Research Expansion Act will make it easier to study the impacts and potential of cannabis.”
Research Is Fundamental
“Research is fundamental to determining the path forward for cannabis policy. Research is essential to better understand the therapeutic benefits of cannabis that have the potential to help millions of Americans struggling with chronic pain, PTSD, multiple sclerosis, anxiety disorders and more.”
“We welcome the enactment of this critical and long overdue legislation, and we know there is still much to be done to address the ongoing damage of the failed war on drugs. Our caucus will continue to work to reimagine the federal government’s approach to cannabis and enact further reforms. In the coming weeks, we are committed to passing other bipartisan, common-sense proposals like the SAFE banking package, the Veterans Equal Access Act, the PREPARE Act, and the Veterans Medical Cannabis Safe Harbor Act.”
(Featured image by The White House (CC BY 3.0 US) via Wikimedia Commons)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Comments are closed for this post.